Your cart is empty.
Männedorf, Switzerland, July 3, 2012 – Tecan has updated the patent pending Gas Control Module (GCM™) for the Infinite® 200 PRO multimode reader to offer simultaneous control of O2 and CO2 concentrations, providing rigorous environmental control for an even wider range of cell biology applications. The original GCM, which was a breakthrough for cellbased experiments, has now been further enhanced to provide increased measurement accuracy and minimize cross-interference for oxygen measurements. Combined with re-designed, independent gas inlets, this offers precise, independent control of both O2 and CO2 levels within the reader, with automatic compensation for variations in the atmospheric partial pressure of CO2 via a unique altitude correction function.
These new and improved features ensure greater biological relevance for a wide range of studies, extending the experimental window for microplate-based investigations of anaerobic or facultative anaerobic bacteria, and allowing close replication of hypoxic or physiological conditions for eukaryotic cells. Together with the Infinite 200 PRO's cell biology oriented functions – including Optimal Cell Reading (OR), linear and orbital shaking, advanced temperature control and automated Z-focusing – this comprehensive solution sets new standards for cell-based assays.
To find out more on the GCM for Tecan's Infinite 200 PRO, visit www.tecan.com/gcm
Tecan Trading AG
Cornelia Kegele, Antonietta Allocca
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).